![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/innocan-pharma-announces-successful-preliminary-safety-evaluation-of-lpt-cbd-in-minipigs-302169230.html
https://www.prnewswire.com/news-releases/innocan-pharma-reports-first-quarter-2024-results-with-revenue-growth-of-over-4x-to-6-8-million-302156218.html
https://www.prnewswire.com/news-releases/fda-has-granted-innocan-pharma-a-meeting-date-for-lpt-cbd-for-chronic-pain-302151666.html
https://www.prnewswire.com/news-releases/innocan-pharma-initiates-fda-approval-process-for-liposome-injection-therapy-for-chronic-pain-302122777.html
https://www.prnewswire.com/news-releases/innocan-pharma-reports-full-year-2023-results-with-revenues-up-nearly-6x-to-13-7m-302104634.html
https://www.prnewswire.com/news-releases/innocan-pharma-paves-its-way-to-lpt-cbd-chemistry-manufacturing-and-controls-cmc-key-milestones-for-fda-approval-302098609.html
https://www.prnewswire.com/news-releases/innocan-pharma-announces-closing-of-private-placement-for-gross-proceeds-of-approximately-c2-million-302089968.html
https://www.prnewswire.com/news-releases/innocan-pharmas-lpt-cbd-has-the-potential-to-support-a-new-therapeutic-venue-for-neurological-disorders-according-to-recent-study-302080319.html
https://www.prnewswire.com/news-releases/innocan-pharma-announces-study-findings-that-lpt-cbd-maintains-its-prolonged-release-in-rabbits-302069810.html
https://www.prnewswire.com/news-releases/innocan-pharma-to-provide-a-corporate-update-via-zoom-livestream-on-february-12-2024-at-400pm-est-302053775.html